The treatment of Backache & GERD with vitamins

Backache and GERD: Mitamins custom make quality formulas for the treatment of Backache & GERD with vitamins. A Backache & GERD formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Backache and GERD

  • Amount Per Serving
    % DV
    Vitamin B12
    500
    mcg
    8333%
    Calcium
    50
    mg
    5%
    Magnesium
    25
    mg
    6%
    Potassium
    50
    mg
    1%
    Lactobacillus acidolphilus
    100
    mg
    *
    Feverfew Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    DL-Phenylalanine
    100
    mg
    *
    Betaine HCl
    100
    mg
    *
    Slippery Elm Extract
    100
    mg
    *
    White Willow Extract
    30
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Backache and GERD Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Mouse Model For Autism Likened To 'Rain Man'
Mice containing a mutated human gene implicated in autism exhibit the poor social skills but increased intelligence akin to the title character's traits in the movie "Rain Man," researchers at UT Southwestern Medical Center have found.The researchers' study also shows how the mutation affects nerve function and provides an animal model that might allow further study of the debilitating condition.
Lexicon Presents Class Of Compounds Modulating TPH1, The Target For Its LX1031 Investigational Drug For Irritable Bowel Syndrome
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) presented data today describing the structure-activity relationship (SAR) of a class of internally-developed compounds that includes LX1031 and other compounds under evaluation by the company as potential treatments for irritable bowel syndrome (IBS) and other gastrointestinal disorders. LX1031 is currently under evaluation in a Phase 1b clinical trial in healthy volunteers.
This information concerning the support of Backache and GERD treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments